Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: Rosemont Pharmaceuticals Ltd., Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, LS11 9XE, UK
Dexsol 2mg/5ml Oral Solution.
| Pharmaceutical Form |
|---|
|
Oral Solution. A colourless to faint yellow solution with odour of mint. |
Dexamethasone 2mg/5ml (as dexamethasone sodium phosphate).
Excipients:
Propylene glycol (E1520) – 450.6mg/5ml
Liquid maltitol (E965) - 1375mg/5ml
Sorbitol, liquid (non-crystallising) (E420) - 700mg/5ml
Benzoic acid (E210) - 5mg/5ml
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response. |
| List of Excipients |
|---|
|
Benzoic acid (E420) |
Bottles: 75ml and 150ml in Amber (Type III) glass.
Closures: HDPE, EPE wadded, tamper evident, child resistant closure.
Rosemont Pharmaceuticals Ltd., Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, LS11 9XE, UK
PL 00427/0137
8th March 2005
| Drug | Countries | |
|---|---|---|
| DEXSOL | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.